Accutar Biotechnology在2024年ASCO年会上公布了在ER+/HER2-乳腺癌患者中开展AC699单一疗法一期试验的数据
2024-06-03 19:43:36Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS
2024-06-03 19:42:49Mavenir在新发布的《Omdia RAN供应商报告中》表现亮眼
2024-06-03 19:41:48Adani Ports签署达累斯萨拉姆港2号集装箱码头30年特许经营合同
2024-06-03 19:41:31Takeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 (rADAMTS13) in Congenital Thrombotic
2024-06-03 19:38:38日本酒造组合中央会将于今年7月在日本举办“2024年日本清酒展”!!
2024-06-03 19:24:09随机文章